Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma

BACKGROUND: Treatment for recurrent glioblastoma is poor, and there is a need for better therapies. Here we retrospectively assessed the efficacy and toxicity of temozolomide plus apatinib, an oral small-molecule tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor 2 in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Jingjing, Li, Cheng, Xue, Fengjun, Qi, Shaopei, Gao, Zhimeng, Yu, Chunjiang, Zhang, Junping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901881/
https://www.ncbi.nlm.nih.gov/pubmed/33634023
http://dx.doi.org/10.3389/fonc.2020.601175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901881/
https://www.ncbi.nlm.nih.gov/pubmed/33634023
http://dx.doi.org/10.3389/fonc.2020.601175

Ejemplares similares